Saint Kitts and Nevis vs United States of America: HPV immunization coverage estimates among primary target cohort (9-14)
Saint Kitts and Nevis
72.0%
in 2025
United States of America
73.0%
in 2025
Saint Kitts and Nevis rank
57th
United States of America rank
54th
HPV immunization coverage estimates among primary target cohort (9-14) over time
- Saint Kitts and Nevis
- United States of America
How they compare
United States of America currently reports 73.0% against 72.0% in Saint Kitts and Nevis, a difference of 1.0%.
The two have swapped places 3 times across 7 shared years of data; in 2019 it was Saint Kitts and Nevis ahead.
Saint Kitts and Nevis ranks 57th and United States of America ranks 54th of 111 countries.
Saint Kitts and Nevis has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Saint Kitts and Nevis | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 90.0% | 68.0% | 22.0% | Saint Kitts and Nevis |
| 2020s | 75.3% | 72.8% | 2.5% | Saint Kitts and Nevis |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hpv immunization coverage estimates among primary target cohort (9-14), Saint Kitts and Nevis or United States of America?
- United States of America, at 73.0% against 72.0% in Saint Kitts and Nevis as of 2025.
- What is the difference in hpv immunization coverage estimates among primary target cohort (9-14) between Saint Kitts and Nevis and United States of America?
- 1.0%, with United States of America ahead.
- How many years of comparable data are there for Saint Kitts and Nevis and United States of America?
- 7 years are reported by both, from 2019 to 2025.
- How do Saint Kitts and Nevis and United States of America rank globally for hpv immunization coverage estimates among primary target cohort (9-14)?
- Saint Kitts and Nevis ranks 57th and United States of America ranks 54th of 111 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HPV immunization coverage estimates among primary target cohort (9-14 years old girls) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.